161 related articles for article (PubMed ID: 37011336)
1. Designing Trials for Neoadjuvant Immune Checkpoint Inhibition in Microsatellite Instability-High Localized Colorectal Cancer.
André T; Cohen R
JCO Oncol Pract; 2023 May; 19(5):261-262. PubMed ID: 37011336
[No Abstract] [Full Text] [Related]
2. Current status and perspectives of immune checkpoint inhibitors for colorectal cancer.
Hirano H; Takashima A; Hamaguchi T; Shida D; Kanemitsu Y;
Jpn J Clin Oncol; 2021 Jan; 51(1):10-19. PubMed ID: 33205813
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant Immunotherapy in Microsatellite-Instability High Nonmetastatic Colorectal Cancer: A Single-institute Experience and Review of the Literature.
Kinney RE; Khalil M
Clin Colorectal Cancer; 2021 Jun; 20(2):e109-e112. PubMed ID: 33722513
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of neoadjuvant immunotherapy in patients with microsatellite instability-high gastrointestinal malignancies: A case series.
Zhang Z; Cheng S; Gong J; Lu M; Zhou J; Zhang X; Li J; Shen L; Peng Z
Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e33-e39. PubMed ID: 32732092
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Immunotherapy Leads to Major Response and Low Recurrence in Localized Mismatch Repair-Deficient Colorectal Cancer.
Xiao BY; Zhang X; Cao TY; Li DD; Jiang W; Kong LH; Tang JH; Han K; Zhang CZ; Mei WJ; Xiao J; Pan ZZ; Li YF; Zhang XS; Ding PR
J Natl Compr Canc Netw; 2023 Jan; 21(1):60-66.e5. PubMed ID: 36630898
[TBL] [Abstract][Full Text] [Related]
6. An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy.
Sibilio P; Belardinilli F; Licursi V; Paci P; Giannini G
Biol Direct; 2022 May; 17(1):10. PubMed ID: 35534873
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite Instability as a Predictor of Outcomes in Colorectal Cancer in the Era of Immune-Checkpoint Inhibitors.
Lengyel CG
Curr Drug Targets; 2021; 22(9):968-976. PubMed ID: 33970843
[TBL] [Abstract][Full Text] [Related]
8. Systemic treatment of mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer-single versus double checkpoint inhibition.
Marinelli D; Sabatini A; Bengala E; Ciurluini F; Picone V; Santini D; Pietrantonio F; Rossini D; Cremolini C
ESMO Open; 2024 Jun; 9(6):103483. PubMed ID: 38833965
[No Abstract] [Full Text] [Related]
9. Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future.
Sahin IH; Zhang J; Saridogan T; Gorantla V; Rhree J; Malhotra M; Thomas R; Hsu D; Saeed A
JCO Oncol Pract; 2023 May; 19(5):251-259. PubMed ID: 36862965
[TBL] [Abstract][Full Text] [Related]
10. [Treatment Strategy with Immune Checkpoint Inhibitors and Genetic Testing for Colorectal Cancer with Microsatellite Instability-High].
Yamazaki K; Kawakami T; Shirasu H; Fushiki K; Murase M; Murakami H
Gan To Kagaku Ryoho; 2022 Jul; 49(7):761-767. PubMed ID: 35851347
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy After Immunotherapy: Response Rescue in a Patient With Microsatellite Instability-high Colorectal Cancer Post-Pembrolizumab.
Das S; Allen A; Berlin J
Clin Colorectal Cancer; 2020 Jun; 19(2):137-140. PubMed ID: 32146081
[TBL] [Abstract][Full Text] [Related]
12. The prognostic and predictive impact of
Park R; Lopes L; Lee S; Riano I; Saeed A
Future Oncol; 2021 Nov; 17(31):4221-4231. PubMed ID: 34323124
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues.
Sahin IH; Ciombor KK; Diaz LA; Yu J; Kim R
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-12. PubMed ID: 35658496
[TBL] [Abstract][Full Text] [Related]
14. Immune Checkpoint Inhibition in Colorectal Cancer: Microsatellite Instability and Beyond.
Cohen R; Rousseau B; Vidal J; Colle R; Diaz LA; André T
Target Oncol; 2020 Feb; 15(1):11-24. PubMed ID: 31786718
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of surgical resection in microsatellite instable colorectal cancer after immune checkpoint inhibitor treatment.
Challine A; Karoui M; De La Fouchardière C; André T; Svrcek M; Meeus P; Dupré A; Paye F; Benoit S; Denet C; Eveno C; Lefèvre JH; Parc Y
Br J Surg; 2023 Aug; 110(9):1043-1045. PubMed ID: 36518094
[No Abstract] [Full Text] [Related]
16. [Immune checkpoint inhibitors in the treatment of colorectal cancer: a review of clinical trials].
Gong XL; Zhao L
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):205-213. PubMed ID: 35340169
[TBL] [Abstract][Full Text] [Related]
17. An update on the use of immunotherapy in patients with colorectal cancer.
Nguyen M; Tipping Smith S; Lam M; Liow E; Davies A; Prenen H; Segelov E
Expert Rev Gastroenterol Hepatol; 2021 Mar; 15(3):291-304. PubMed ID: 33138649
[No Abstract] [Full Text] [Related]
18. Towards a precision immune checkpoint blockade immunotherapy in patients with colorectal cancer: Strategies and perspectives.
Cui G
Biomed Pharmacother; 2022 May; 149():112923. PubMed ID: 36068782
[TBL] [Abstract][Full Text] [Related]
19. The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors.
Corti F; Lonardi S; Intini R; Salati M; Fenocchio E; Belli C; Borelli B; Brambilla M; Prete AA; Quarà V; Antista M; Fassan M; Morano F; Spallanzani A; Ambrosini M; Curigliano G; de Braud F; Zagonel V; Fucà G; Pietrantonio F
Eur J Cancer; 2021 Jun; 150():155-167. PubMed ID: 33901794
[TBL] [Abstract][Full Text] [Related]
20. [The Efficacy of Immune Checkpoint Inhibitors as First-line Treatment in Microsatellite-instability-high Metastatic Colorectal Cancer].
Lee JY
Korean J Gastroenterol; 2021 May; 77(5):261-262. PubMed ID: 34035206
[No Abstract] [Full Text] [Related]
[Next] [New Search]
